A
Agilent Technologies, Inc. NYSE Listed Nov 18, 1999$127.06
After hrs
$127.06
+0.00%
Mkt Cap $35.9B
52w Low $108.35
36.0% of range
52w High $160.27
50d MA $120.94
200d MA $130.43
P/E (TTM)
27.2x
EV/EBITDA
19.9x
P/B
5.3x
Debt/Equity
0.5x
ROE
18.7%
P/FCF
31.3x
RSI (14)
35.50
ATR (14)
$3.81
Beta
1.30
50d MA
$120.94
200d MA
$130.43
Avg Volume
2.5M
Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; vacuum pumps, and measurement technologies. The Diagnostics and Genomics segment provides arrays for DNA mutation detection, genotyping, gene copy number determination, identification of gene rearrangements, DNA methylation profiling, gene expression profiling, next generation sequencing, target enrichment and genetic data management, and interpretation support software; and produces synthesized oligonucleotide. It also offers immunohistochemistry in situ hybridization, and hematoxylin and eosin staining and special staining; consumables, and software for quality control analysis of nucleic acid samples; and reagents for use in turbidimetry and flow cytometry, as well as develops liquid-based pharmacodiagnostics. The Agilent CrossLab segment provides GC and LC columns, sample preparation products, custom chemistries, and laboratory instrument supplies; and startup, operational, training, compliance support, software as a service, asset management, and consultation services. The company markets its products through direct sales, distributors, resellers, manufacturer's representatives, and electronic commerce. Agilent Technologies, Inc. was incorporated in 1999 and is headquartered in Santa Clara, California.
5301 Stevens Creek Boulevard · Santa Clara, CA 95051 · US
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 25, 2026 | AMC | 1.37 | 1.36 | -0.7% | 124.72 | -2.3% | -3.0% | +0.3% | -2.6% | +0.7% | +1.3% | — |
| Nov 24, 2025 | AMC | 1.58 | 1.59 | +0.4% | 153.60 | -1.8% | +2.3% | -1.8% | -0.6% | -2.2% | -0.9% | — |
| Aug 27, 2025 | AMC | 1.37 | 1.37 | +0.0% | 118.69 | +0.1% | +5.3% | +0.6% | -0.4% | +0.0% | +2.6% | — |
| May 28, 2025 | AMC | 1.26 | 1.31 | +4.0% | 110.88 | +5.5% | +2.2% | -1.2% | -0.8% | +1.5% | +1.9% | — |
| Feb 26, 2025 | AMC | 1.28 | 1.31 | +2.3% | 134.47 | -4.2% | -5.5% | +0.7% | -1.2% | -2.6% | +2.8% | — |
| Nov 25, 2024 | AMC | 1.41 | 1.46 | +3.5% | 134.49 | -5.6% | -0.1% | +2.8% | -0.1% | +1.2% | -0.2% | — |
| Aug 21, 2024 | AMC | 1.26 | 1.32 | +4.8% | 139.99 | +3.9% | +0.2% | +0.5% | -0.3% | +0.4% | -0.0% | — |
| May 29, 2024 | AMC | 1.19 | 1.22 | +2.5% | 145.48 | -13.9% | -9.7% | -0.8% | +0.8% | -0.4% | +2.1% | — |
| Feb 27, 2024 | AMC | 1.22 | 1.29 | +5.7% | 132.55 | +5.5% | +3.4% | +0.3% | +1.2% | +2.7% | +1.0% | — |
| Nov 20, 2023 | AMC | 1.34 | 1.38 | +3.0% | 113.98 | +6.6% | +8.7% | +0.1% | +2.1% | -1.3% | -0.2% | — |
| Aug 15, 2023 | AMC | 1.37 | 1.43 | +4.4% | 125.65 | -2.9% | -3.4% | -0.4% | -1.3% | -0.3% | -1.0% | — |
| May 23, 2023 | AMC | 1.26 | 1.27 | +0.8% | 128.64 | -10.4% | -5.9% | -1.2% | +0.8% | -2.2% | -1.7% | — |
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 11 | Piper Sandler | Initiates | Neutral | $150 | $131.62 | $131.45 | -0.1% | -1.6% | +0.2% | +0.6% | -1.7% | -3.1% |
| May 28 | BofA Securities | Upgrade | Neutral → Buy | $145 | $115.84 | $133.00 | +14.8% | +16.9% | +0.1% | +0.3% | -0.7% | +1.7% |
| May 27 | RBC Capital Mkts | Initiates | Outperform | $153 | $115.08 | $116.00 | +0.8% | +0.7% | +16.9% | +0.1% | +0.3% | -0.7% |
| Apr 28 | KeyBanc Capital Markets | Maintains | Sector Weight → Sector Weight | — | $115.62 | $116.23 | +0.5% | -0.6% | -3.1% | +3.8% | -0.9% | -2.0% |
| Apr 14 | Barclays | Maintains | Overweight → Overweight | — | $117.50 | $118.04 | +0.5% | +2.5% | -0.5% | -1.3% | +3.1% | -0.7% |
| Apr 13 | TD Cowen | Maintains | Buy → Buy | — | $115.06 | $114.94 | -0.1% | +2.1% | +2.5% | -0.5% | -1.3% | +3.1% |
| Apr 6 | Evercore ISI | Maintains | Outperform → Outperform | — | $115.48 | $115.14 | -0.3% | -0.6% | -0.8% | +2.7% | -1.3% | -0.3% |
| Mar 3 | Morgan Stanley | Maintains | Overweight → Overweight | — | $118.17 | $116.64 | -1.3% | +0.7% | +1.3% | -2.0% | -2.6% | +1.4% |
| Feb 26 | UBS | Maintains | Buy → Buy | — | $124.72 | $121.89 | -2.3% | -3.0% | +0.3% | -2.6% | +0.7% | +1.3% |
| Feb 26 | TD Cowen | Maintains | Buy → Buy | — | $124.72 | $121.89 | -2.3% | -3.0% | +0.3% | -2.6% | +0.7% | +1.3% |
| Feb 26 | Barclays | Maintains | Overweight → Overweight | — | $124.72 | $121.89 | -2.3% | -3.0% | +0.3% | -2.6% | +0.7% | +1.3% |
| Feb 26 | Wells Fargo | Maintains | Overweight → Overweight | — | $124.72 | $121.89 | -2.3% | -3.0% | +0.3% | -2.6% | +0.7% | +1.3% |
| Jan 5 | Evercore ISI | Upgrade | In Line → Outperform | — | $137.95 | $137.67 | -0.2% | +3.6% | +3.3% | +0.1% | -1.4% | +1.9% |
| Dec 15 | Barclays | Upgrade | Equal Weight → Overweight | — | $139.68 | $141.82 | +1.5% | +0.7% | -1.0% | -1.8% | +0.2% | +0.2% |
| Nov 25 | Barclays | Maintains | Equal Weight → Equal Weight | — | $153.60 | $150.78 | -1.8% | +2.3% | -1.8% | -0.6% | -2.2% | -0.9% |
| Nov 25 | Baird | Maintains | Outperform → Outperform | — | $153.60 | $150.78 | -1.8% | +2.3% | -1.8% | -0.6% | -2.2% | -0.9% |
| Nov 25 | UBS | Maintains | Buy → Buy | — | $153.60 | $150.78 | -1.8% | +2.3% | -1.8% | -0.6% | -2.2% | -0.9% |
| Nov 25 | Wells Fargo | Maintains | Overweight → Overweight | — | $153.60 | $150.78 | -1.8% | +2.3% | -1.8% | -0.6% | -2.2% | -0.9% |
| Nov 25 | BofA Securities | Maintains | Neutral → Neutral | — | $153.60 | $150.78 | -1.8% | +2.3% | -1.8% | -0.6% | -2.2% | -0.9% |
| Nov 25 | Citigroup | Maintains | Buy → Buy | — | $153.60 | $150.78 | -1.8% | +2.3% | -1.8% | -0.6% | -2.2% | -0.9% |
| Nov 25 | JP Morgan | Maintains | Overweight → Overweight | — | $153.60 | $150.78 | -1.8% | +2.3% | -1.8% | -0.6% | -2.2% | -0.9% |
| Oct 14 | TD Cowen | Maintains | Buy → Buy | — | $138.23 | $136.27 | -1.4% | -0.1% | +1.2% | +1.0% | +0.6% | +0.8% |
| Oct 9 | JP Morgan | Maintains | Overweight → Overweight | — | $140.81 | $140.28 | -0.4% | -0.5% | -2.5% | +1.2% | -0.1% | +1.2% |
| Oct 8 | UBS | Upgrade | Neutral → Buy | — | $138.56 | $140.36 | +1.3% | +1.6% | -0.5% | -2.5% | +1.2% | -0.1% |
| Oct 7 | Evercore ISI | Maintains | In Line → In Line | — | $141.61 | $141.86 | +0.2% | -2.2% | +1.6% | -0.5% | -2.5% | +1.2% |
| Oct 2 | Barclays | Maintains | Equal Weight → Equal Weight | — | $138.58 | $137.55 | -0.7% | +0.1% | +2.1% | -0.0% | -2.2% | +1.6% |
| Sep 15 | Wells Fargo | Maintains | Overweight → Overweight | — | $123.24 | $123.99 | +0.6% | +1.9% | +1.2% | -0.4% | +0.7% | -1.0% |
| Aug 29 | Barclays | Maintains | Equal Weight → Equal Weight | — | $124.96 | $125.00 | +0.0% | +0.6% | -0.4% | +0.0% | +2.6% | +0.2% |
| Aug 28 | Baird | Maintains | Outperform → Outperform | — | $118.69 | $118.80 | +0.1% | +5.3% | +0.6% | -0.4% | +0.0% | +2.6% |
| Aug 28 | Evercore ISI | Maintains | In Line → In Line | — | $118.69 | $118.80 | +0.1% | +5.3% | +0.6% | -0.4% | +0.0% | +2.6% |
| Aug 28 | Wells Fargo | Maintains | Overweight → Overweight | — | $118.69 | $118.80 | +0.1% | +5.3% | +0.6% | -0.4% | +0.0% | +2.6% |
| Jul 8 | Evercore ISI | Maintains | In Line → In Line | — | $119.25 | $119.58 | +0.3% | +1.5% | +0.2% | +2.4% | -0.7% | -2.6% |
| Jun 24 | Evercore ISI | Maintains | In Line → In Line | — | $116.13 | $117.33 | +1.0% | +1.3% | +0.8% | +0.7% | -0.2% | -1.0% |
| Jun 24 | Barclays | Maintains | Equal Weight → Equal Weight | — | $116.13 | $117.33 | +1.0% | +1.3% | +0.8% | +0.7% | -0.2% | -1.0% |
| May 29 | UBS | Maintains | Neutral → Neutral | — | $110.88 | $116.95 | +5.5% | +2.2% | -1.2% | -0.8% | +1.5% | +1.9% |
| May 29 | JP Morgan | Maintains | Overweight → Overweight | — | $110.88 | $116.95 | +5.5% | +2.2% | -1.2% | -0.8% | +1.5% | +1.9% |
| May 22 | Baird | Maintains | Outperform → Outperform | — | $108.91 | $108.36 | -0.5% | +0.7% | -1.0% | +2.5% | -0.3% | +2.2% |
| Apr 21 | Jefferies | Maintains | Hold → Hold | — | $102.48 | $101.85 | -0.6% | -2.2% | +2.5% | +2.1% | +1.9% | -0.7% |
| Apr 17 | Wells Fargo | Maintains | Overweight → Overweight | — | $102.70 | $102.63 | -0.1% | -0.2% | -2.2% | +2.5% | +2.1% | +1.9% |
| Apr 16 | Bernstein | Maintains | Market Perform → Market Perform | — | $103.12 | $103.22 | +0.1% | -0.4% | -0.2% | -2.2% | +2.5% | +2.1% |
| Apr 14 | BofA Securities | Maintains | Neutral → Neutral | — | $102.71 | $104.94 | +2.2% | +2.4% | -2.0% | -0.4% | -0.2% | -2.2% |
| Apr 10 | Barclays | Maintains | Equal Weight → Equal Weight | — | $107.05 | $104.82 | -2.1% | -6.6% | +2.8% | +2.4% | -2.0% | -0.4% |
| Feb 27 | Barclays | Maintains | Equal Weight → Equal Weight | — | $134.47 | $128.78 | -4.2% | -5.5% | +0.7% | -1.2% | -2.6% | +2.8% |
| Feb 27 | Baird | Maintains | Outperform → Outperform | — | $134.47 | $128.78 | -4.2% | -5.5% | +0.7% | -1.2% | -2.6% | +2.8% |
| Feb 10 | Barclays | Upgrade | Underweight → Equal Weight | — | $145.21 | $145.58 | +0.3% | -1.0% | -1.4% | -2.6% | -1.2% | -1.3% |
| Jan 27 | BofA Securities | Maintains | Neutral → Neutral | — | $151.44 | $151.56 | +0.1% | -0.3% | -0.4% | -2.2% | +2.9% | +0.1% |
| Jan 10 | Bernstein | Maintains | Market Perform → Market Perform | — | $137.00 | $134.75 | -1.6% | +0.3% | +3.3% | +1.0% | -0.8% | +1.8% |
| Dec 13 | BofA Securities | Maintains | Neutral → Neutral | — | $140.91 | $140.36 | -0.4% | -1.4% | -1.0% | -0.9% | -2.5% | +0.1% |
| Dec 9 | Wells Fargo | Maintains | Overweight → Overweight | — | $140.58 | $140.81 | +0.2% | +2.4% | -1.4% | -0.5% | -0.2% | -1.4% |
| Nov 27 | Barclays | Maintains | Underweight → Underweight | — | $134.37 | $134.69 | +0.2% | +2.8% | -0.1% | +1.2% | -0.2% | +0.7% |
| Date | Insider | Title | Type | Shares | Price | Value | Owned After | D1% | D5% |
|---|---|---|---|---|---|---|---|---|---|
| May 29, 2026 | Dolsten MikaelDir | — | Sell | 1,600 | $135.42 | $217K | 5,548 | +1.74% | +2.10% |
8-K · 5.02
!!! Very High
Agilent Technologies, Inc. -- 8-K 5.02: Executive Change
May 27
8-K · 5.02
!!! Very High
Agilent Technologies, Inc. -- 8-K 5.02: Executive Change
Agilent Technologies (A) experienced a senior management departure with Bret DiMarco's resignation as Senior Vice President, which may signal organizational changes but lacks detail on reasons or succession plans.
May 4
8-K · 5.02
!!! Very High
Unknown — 8-K 5.02: Executive Change
DiMarco's departure signals potential leadership instability and removes equity incentives for 2026, likely indicating a planned exit that could pressure stock performance if investors lose confidence in management continuity.
Apr 6
8-K · 7.01
! Medium
Unknown — 8-K 7.01: Regulation FD Disclosure
This Regulation FD disclosure likely contains forward-looking statements about company plans or expectations, signaling management's optimistic outlook but with limited legal liability if projections fail to materialize.
Apr 3
8-K · 5.02
!!! Very High
Unknown — 8-K 5.02: Executive Change
An executive departure at Agilent Technologies could signal leadership transitions or strategic changes, potentially affecting operational continuity and investor confidence in company direction.
Apr 3
8-K · 5.02
!!! Very High
Unknown — 8-K 5.02: Executive Change
A leadership transition to a new CFO effective March 30, 2026 signals potential strategic shifts in financial management and capital allocation that investors should monitor for signs of operational changes or guidance updates.
Mar 27
8-K · 5.03
! Medium
Unknown — 8-K 5.03: Amendment to Articles / Bylaws
Agilent's strong 88% shareholder attendance at its annual meeting signals robust investor engagement and validates management's governance practices, reducing proxy contest risks.
Mar 20
8-K · 5.02
!!! Very High
Unknown — 8-K 5.02: Executive Change
An executive's departure with a general release suggests potential internal turmoil or strategic disagreement, which could create uncertainty about company direction and leadership stability that investors should monitor closely.
Mar 17
8-K · 5.02
!!! Very High
Agilent Technologies Inc. -- 8-K 5.02: Executive Change
Agilent Technologies' Vice President and Principal Accounting Officer Rodney Gonsalves will retire in January 2027, requiring investors to monitor leadership transition execution and accounting function continuity.
Mar 6
8-K
Agilent Technologies Inc. -- 8-K Filing
Agilent Technologies disclosed its use of non-GAAP financial metrics in investor communications, emphasizing that these supplementary measures complement but do not replace standard GAAP reporting requirements.
Feb 25
Institutional (13F) — Top 20
All ↗
| # | Manager | Shares | Value | Chg | Period |
|---|---|---|---|---|---|
| 1 | Vanguard Capital Management Llc | 18,381,030 | $2.1B | New | Mar 2026 |
| 2 | Vanguard Portfolio Management Llc | 14,352,682 | $1.6B | New | Mar 2026 |
| 3 | Morgan Stanley | 10,083,762 | $1.4B | Added | Dec 2025 |
| 4 | Pictet Asset Management Holding Sa | 4,664,881 | $635M | Reduced | Dec 2025 |
| 5 | State Farm Mutual Automobile Insurance Co | 3,825,278 | $436M | — | Mar 2026 |
| 6 | Northern Trust Corp | 3,700,025 | $422M | Reduced | Mar 2026 |
| 7 | Cantillon Capital Management Llc | 3,092,145 | $397M | Reduced | Sep 2025 |
| 8 | Impax Asset Management Group Plc | 2,595,597 | $353M | Reduced | Dec 2025 |
| 9 | Aqr Capital Management Llc | 2,991,479 | $339M | Added | Mar 2026 |
| 10 | Bank Of New York Mellon Corp | 2,793,604 | $318M | Reduced | Mar 2026 |
| 11 | Troy Asset Management Ltd | 2,413,232 | $275M | — | Mar 2026 |
| 12 | Nordea Investment Management Ab | 2,363,299 | $267M | Added | Mar 2026 |
| 13 | Invesco Ltd. | 2,314,028 | $264M | Reduced | Mar 2026 |
| 14 | Jpmorgan Chase & Co | 2,321,503 | $260M | Added | Mar 2026 |
| 15 | Qube Research & Technologies Ltd | 2,280,319 | $260M | Added | Mar 2026 |
| 16 | Citadel Advisors Llc | 1,801,714 | $205M | Added | Mar 2026 |
| 17 | William Blair Investment Management, Llc | 1,795,764 | $205M | Reduced | Mar 2026 |
| 18 | D.e. Shaw & Co | 1,695,923 | $193M | Added | Mar 2026 |
| 19 | Sg Americas Securities, Llc | 1,674,856 | $191M | Added | Mar 2026 |
| 20 | Bank Of America Corp /de/ | 1,634,555 | $186M | Added | Mar 2026 |
Mutual Funds / ETFs (N-PORT) — Top 20
All ↗
Valuation
Market Cap
$35.89B
Enterprise Value
$36.57B
P/E (TTM)
27.21x
Forward P/E
21.28x
PEG Ratio
9.41x
P/B
5.33x
P/S
5.19x
P/FCF
31.32x
EV/EBITDA
19.93x
Shares Out
284.0M
Financials (TTM)
Revenue
$6.95B
Net Income
$1.30B
EBITDA
$1.83B
Free Cash Flow
$1.15B
Op Cash Flow
$1.56B
EPS Basic
$4.59
EPS Diluted
$4.57
EPS Forward
$5.97
Gross Margin
52.4%
Op Margin
21.3%
Net Margin
18.8%
Balance Sheet
Total Assets
$12.73B
Total Liab.
$5.99B
Total Equity
$6.74B
Cash
$1.79B
LT Debt
$3.05B
Book Value/Sh
$23.82
Debt/Equity
0.50x
Current Ratio
1.96
Quick Ratio
1.52
Returns & Growth
ROE
18.7%
ROA
10.1%
ROIC
12.6%
Rev Growth YoY
+6.7%
EPS Growth YoY
+3.4%
Price Returns
2W
+19.7%
1M
+17.3%
3M
+11.7%
6M
-11.7%
12M
+21.1%
Technicals
52W High
$160.27
52W Low
$108.35
50d MA
$120.94
200d MA
$130.43
RSI (14)
35.50
ATR (14)
$3.81
Beta
1.30
Avg Volume
2.5M
Dividends
Div Rate
$1.00
Div Yield
0.9%
Frequency
4
Ex-Div Date
Mar 31, 2026
Analyst Price Targets
Consensus
$166.00
High
$180.00
Low
$140.00
Median
$167.50
Data updated apr 24, 2026 10:01am
· Source: financialmodelingprep.com